In Q1 2026, Artisan Partners initiated new investments in Edwards Lifesciences, Eli Lilly, and Roblox, while increasing holdings in Linde, Shopify, Amazon, Woodward, and Spotify. The firm ended its investment campaigns in Netflix, Snowflake, and RELX during the same period. These portfolio changes reflect Artisan Partners' strategic adjustments to capture growth opportunities and optimize returns across various sectors. The firm continues to manage diverse investment strategies for institutional clients globally.
Eli Lilly announced it will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion upfront, gaining access to experimental drugs targeting mental health conditions like treatment-resistant depression. AtaiBeckley's lead drug, a DMT-based nasal sp...
Eli Lilly's stock is projected to grow about 76% over the next three years, reaching around $2,091 per share. This growth is fueled by strong revenue increases from blockbuster drugs like Mounjaro and Zepbound, which contributed $6.7 billion in new r...
